Supernus Pharmaceuticals, Inc.

GLENMEDE TRUST CO NA SUPN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

239,183

Value ($000)

11,887

Weight

0.1%

2019 Q4 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	11,887	0.1%	239,183	12/31/2025
2025 Q1	5/15/2025	525	0.0%	16,025	3/31/2025
2023 Q2	8/14/2023	614	0.0%	16,946	6/30/2023
2023 Q1	5/15/2023	614	0.0%	16,946	3/31/2023
2022 Q4	2/14/2023	564	0.0%	15,823	12/31/2022
2022 Q3	11/16/2022	532	0.0%	15,744	9/30/2022
2022 Q2	8/15/2022	456	0.0%	15,807	6/30/2022
2022 Q1	5/16/2022	9,379	0.0%	290,217	3/31/2022
2021 Q4	2/15/2022	16,239	0.1%	556,929	12/31/2021
2021 Q3	11/15/2021	15,032	0.1%	563,675	9/30/2021
2021 Q2	8/16/2021	17,485	0.1%	567,929	6/30/2021
2021 Q1	5/18/2021	14,908	0.1%	569,461	3/31/2021
2020 Q4	2/16/2021	12,371	0.1%	491,734	12/31/2020
2020 Q3	11/16/2020	11,054	0.1%	530,460	9/30/2020
2020 Q2	8/14/2020	14,533	0.1%	611,964	6/30/2020
2020 Q1	5/20/2020	18,549	0.1%	782,079	3/31/2020
2019 Q4	2/12/2020	18,549	0.1%	782,079	12/31/2019